Selected research
Market Outlook & Growth Opportunities
Global Evidence-Based Mental Health Apps Market Outlook and Growth Opportunities 2026
Market perspective
The global Evidence-Based Mental Health Apps market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Evidence-Based Mental Health Apps is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Evidence-Based Mental Health Apps is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Evidence-Based Mental Health Apps is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Evidence-Based Mental Health Apps market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Evidence-Based Mental Health Apps market include Moodfit, Talkspace, Headspace, iBreathe, MindShift, CBT-i Coach, Happify, Bearable and Medisafe, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Evidence-Based Mental Health Apps market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Evidence-Based Mental Health Apps and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Evidence-Based Mental Health Apps revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Evidence-Based Mental Health Apps market.
Evidence-Based Mental Health Apps Segment by Company
Moodfit
Talkspace
Headspace
iBreathe
MindShift
CBT-i Coach
Happify
Bearable
Medisafe
BetterHelp
Breathe, Think, Do With Sesame
I Am Sober
Calm
Worry Watch
Evidence-Based Mental Health Apps Segment by Type
iOS
Android
Evidence-Based Mental Health Apps Segment by Application
Adults
Children
Evidence-Based Mental Health Apps Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Evidence-Based Mental Health Apps status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Evidence-Based Mental Health Apps key companies, revenue, market share, and recent developments.
3. To split the Evidence-Based Mental Health Apps breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Evidence-Based Mental Health Apps market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Evidence-Based Mental Health Apps significant trends, drivers, influence factors in global and regions.
6. To analyze Evidence-Based Mental Health Apps competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Evidence-Based Mental Health Apps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Evidence-Based Mental Health Apps and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Evidence-Based Mental Health Apps.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Evidence-Based Mental Health Apps industry.
Chapter 3: Detailed analysis of Evidence-Based Mental Health Apps company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Evidence-Based Mental Health Apps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Evidence-Based Mental Health Apps in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- iOS
- Android
Applications
- Adults
- Children
Companies covered
- Moodfit
- Talkspace
- Headspace
- iBreathe
- MindShift
- CBT-i Coach
- Happify
- Bearable
- Medisafe
- BetterHelp
- Breathe, Think, Do With Sesame
- I Am Sober
- Calm
- Worry Watch
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Evidence-Based Mental Health Apps Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Evidence-Based Mental Health Apps Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Evidence-Based Mental Health Apps Market Dynamics
- 2.1 Evidence-Based Mental Health Apps Industry Trends
- 2.2 Evidence-Based Mental Health Apps Industry Drivers
- 2.3 Evidence-Based Mental Health Apps Industry Opportunities and Challenges
- 2.4 Evidence-Based Mental Health Apps Industry Restraints
3 Evidence-Based Mental Health Apps Market by Company
- 3.1 Global Evidence-Based Mental Health Apps Company Revenue Ranking in 2025
- 3.2 Global Evidence-Based Mental Health Apps Revenue by Company (2021-2026)
- 3.3 Global Evidence-Based Mental Health Apps Company Ranking (2024-2026)
- 3.4 Global Evidence-Based Mental Health Apps Company Manufacturing Base and Headquarters
- 3.5 Global Evidence-Based Mental Health Apps Company Product Type and Application
- 3.6 Global Evidence-Based Mental Health Apps Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Evidence-Based Mental Health Apps Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Evidence-Based Mental Health Apps Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Evidence-Based Mental Health Apps Market by Type
- 4.1 Evidence-Based Mental Health Apps Type Introduction
- 4.1.1 iOS
- 4.1.2 Android
- 4.2 Global Evidence-Based Mental Health Apps Sales Value by Type
- 4.2.1 Global Evidence-Based Mental Health Apps Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Evidence-Based Mental Health Apps Sales Value by Type (2021-2032)
- 4.2.3 Global Evidence-Based Mental Health Apps Sales Value Share by Type (2021-2032)
5 Evidence-Based Mental Health Apps Market by Application
- 5.1 Evidence-Based Mental Health Apps Application Introduction
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Evidence-Based Mental Health Apps Sales Value by Application
- 5.2.1 Global Evidence-Based Mental Health Apps Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Evidence-Based Mental Health Apps Sales Value by Application (2021-2032)
- 5.2.3 Global Evidence-Based Mental Health Apps Sales Value Share by Application (2021-2032)
6 Evidence-Based Mental Health Apps Regional Value Analysis
- 6.1 Global Evidence-Based Mental Health Apps Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Evidence-Based Mental Health Apps Sales Value by Region (2021-2032)
- 6.2.1 Global Evidence-Based Mental Health Apps Sales Value by Region: 2021-2026
- 6.2.2 Global Evidence-Based Mental Health Apps Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Evidence-Based Mental Health Apps Sales Value (2021-2032)
- 6.3.2 North America Evidence-Based Mental Health Apps Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Evidence-Based Mental Health Apps Sales Value (2021-2032)
- 6.4.2 Europe Evidence-Based Mental Health Apps Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Evidence-Based Mental Health Apps Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Evidence-Based Mental Health Apps Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Evidence-Based Mental Health Apps Sales Value (2021-2032)
- 6.6.2 South America Evidence-Based Mental Health Apps Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Evidence-Based Mental Health Apps Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Evidence-Based Mental Health Apps Sales Value Share by Country, 2025 VS 2032
7 Evidence-Based Mental Health Apps Country-level Value Analysis
- 7.1 Global Evidence-Based Mental Health Apps Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Evidence-Based Mental Health Apps Sales Value by Country (2021-2032)
- 7.2.1 Global Evidence-Based Mental Health Apps Sales Value by Country (2021-2026)
- 7.2.2 Global Evidence-Based Mental Health Apps Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.7.2 France Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.14.2 China Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.17.2 India Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Evidence-Based Mental Health Apps Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Evidence-Based Mental Health Apps Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Evidence-Based Mental Health Apps Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Moodfit
- 8.1.1 Moodfit Company Information
- 8.1.2 Moodfit Business Overview
- 8.1.3 Moodfit Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.1.4 Moodfit Evidence-Based Mental Health Apps Product Portfolio
- 8.1.5 Moodfit Recent Developments
- 8.2 Talkspace
- 8.2.1 Talkspace Company Information
- 8.2.2 Talkspace Business Overview
- 8.2.3 Talkspace Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.2.4 Talkspace Evidence-Based Mental Health Apps Product Portfolio
- 8.2.5 Talkspace Recent Developments
- 8.3 Headspace
- 8.3.1 Headspace Company Information
- 8.3.2 Headspace Business Overview
- 8.3.3 Headspace Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.3.4 Headspace Evidence-Based Mental Health Apps Product Portfolio
- 8.3.5 Headspace Recent Developments
- 8.4 iBreathe
- 8.4.1 iBreathe Company Information
- 8.4.2 iBreathe Business Overview
- 8.4.3 iBreathe Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.4.4 iBreathe Evidence-Based Mental Health Apps Product Portfolio
- 8.4.5 iBreathe Recent Developments
- 8.5 MindShift
- 8.5.1 MindShift Company Information
- 8.5.2 MindShift Business Overview
- 8.5.3 MindShift Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.5.4 MindShift Evidence-Based Mental Health Apps Product Portfolio
- 8.5.5 MindShift Recent Developments
- 8.6 CBT-i Coach
- 8.6.1 CBT-i Coach Company Information
- 8.6.2 CBT-i Coach Business Overview
- 8.6.3 CBT-i Coach Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.6.4 CBT-i Coach Evidence-Based Mental Health Apps Product Portfolio
- 8.6.5 CBT-i Coach Recent Developments
- 8.7 Happify
- 8.7.1 Happify Company Information
- 8.7.2 Happify Business Overview
- 8.7.3 Happify Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.7.4 Happify Evidence-Based Mental Health Apps Product Portfolio
- 8.7.5 Happify Recent Developments
- 8.8 Bearable
- 8.8.1 Bearable Company Information
- 8.8.2 Bearable Business Overview
- 8.8.3 Bearable Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.8.4 Bearable Evidence-Based Mental Health Apps Product Portfolio
- 8.8.5 Bearable Recent Developments
- 8.9 Medisafe
- 8.9.1 Medisafe Company Information
- 8.9.2 Medisafe Business Overview
- 8.9.3 Medisafe Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.9.4 Medisafe Evidence-Based Mental Health Apps Product Portfolio
- 8.9.5 Medisafe Recent Developments
- 8.10 BetterHelp
- 8.10.1 BetterHelp Company Information
- 8.10.2 BetterHelp Business Overview
- 8.10.3 BetterHelp Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.10.4 BetterHelp Evidence-Based Mental Health Apps Product Portfolio
- 8.10.5 BetterHelp Recent Developments
- 8.11 Breathe, Think, Do With Sesame
- 8.11.1 Breathe, Think, Do With Sesame Company Information
- 8.11.2 Breathe, Think, Do With Sesame Business Overview
- 8.11.3 Breathe, Think, Do With Sesame Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.11.4 Breathe, Think, Do With Sesame Evidence-Based Mental Health Apps Product Portfolio
- 8.11.5 Breathe, Think, Do With Sesame Recent Developments
- 8.12 I Am Sober
- 8.12.1 I Am Sober Company Information
- 8.12.2 I Am Sober Business Overview
- 8.12.3 I Am Sober Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.12.4 I Am Sober Evidence-Based Mental Health Apps Product Portfolio
- 8.12.5 I Am Sober Recent Developments
- 8.13 Calm
- 8.13.1 Calm Company Information
- 8.13.2 Calm Business Overview
- 8.13.3 Calm Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.13.4 Calm Evidence-Based Mental Health Apps Product Portfolio
- 8.13.5 Calm Recent Developments
- 8.14 Worry Watch
- 8.14.1 Worry Watch Company Information
- 8.14.2 Worry Watch Business Overview
- 8.14.3 Worry Watch Evidence-Based Mental Health Apps Revenue and Gross Margin (2021-2026)
- 8.14.4 Worry Watch Evidence-Based Mental Health Apps Product Portfolio
- 8.14.5 Worry Watch Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst